585
Views
48
CrossRef citations to date
0
Altmetric
Review

The role of novel biomarkers in predicting diabetic nephropathy: a review

Pages 221-231 | Published online: 17 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Samia A. Ahmed, Wessam M. Aziz, Sylvia E. Shaker, Dalia B. Fayed & Heba Shawky. (2022) Urinary transferrin and proinflammatory markers predict the earliest diabetic nephropathy onset. Biomarkers 27:2, pages 178-187.
Read now
Houcine Dab, Amel Chehidi, Mounira Tlili, Anwar Ben Saad, Abdelmajid Khabir & Lazhar Zourgui. (2022) Cardiac extracellular matrix modulation in a rat-diabetic model: biochemical and anti-oxidant beneficial effect of pomegranate (Punica granatum) peel extract. Biomarkers 27:1, pages 50-59.
Read now

Articles from other publishers (46)

Carolin Herzog, Katrin Bose, Maximilian J. Ganz, Peter R. Mertens & Florian G. Scurt. (2023) Aktuelles zu diagnostischen und prognostischen Biomarkern einer diabetischen NephropathieUpdate on diagnostic and prognostic biomarkers for diabetic nephropathy. Die Diabetologie 19:3, pages 238-250.
Crossref
Sheng Ding, Yi Yang, Yuming Zheng, Jinling Xu, Yangyang Cheng, Wei Wei, Fuding Yu, Li Li, Menglan Li, Mengjie Wang, Zhongjing Wang & Guangda Xiang. (2023) Diagnostic Value of the Combined Measurement of Serum HCY and NRG4 in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy. Journal of Personalized Medicine 13:3, pages 556.
Crossref
Jelena Vekic, Anca Pantea Stoian & Manfredi Rizzo. (2023) Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients. Journal of Diabetes and its Complications 37:3, pages 108412.
Crossref
Elfiani Elfiani, Anggelia Puspasari & Zulkhair Ali. 2023. Biomarkers in Diabetes. Biomarkers in Diabetes 469 483 .
Bamidele Stephen Ajilore & Bosede Olaitan Ajilore. 2023. Biomarkers in Diabetes. Biomarkers in Diabetes 891 908 .
Hui Yu, Hongping Wang, Xue Su, Aili Cao, Xingmei Yao, Yunman Wang, Bingbing Zhu, Hao Wang & Ji Fang. (2022) Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. BMC Nephrology 23:1.
Crossref
Ganesh Veluri & Murugan Mannangatti. (2022) Urinary Nephrin is a Sensitive Marker to Predict Early Onset of Nephropathy in Type 2 Diabetes Mellitus. Journal of Laboratory Physicians 14:04, pages 497-504.
Crossref
Kriti Kushwaha, Uma KabraRupal Dubey & Jeena Gupta. (2022) Diabetic Nephropathy: Pathogenesis to Cure. Current Drug Targets 23:15, pages 1418-1429.
Crossref
İsmet EROGLU, Hakan KORKMAZ, Kuyaş H. OZTURK, Fevziye B. SIRIN, Sonmez SEVIK & Barıs AFSAR. (2022) New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203. Minerva Endocrinology 47:3.
Crossref
Samuel N. Uwaezuoke, Chioma L. Odimegwu, Ngozi R. Mbanefo & Ikenna C. Eze. (2022) Posterior urethral valve in children: Using novel biomarkers as an early predictive tool for the onset and progression of chronic kidney disease. Frontiers in Urology 2.
Crossref
Carmen Muntean, Iuliana Magdalena Starcea & Claudia Banescu. (2022) Diabetic kidney disease in pediatric patients: A current review. World Journal of Diabetes 13:8, pages 587-599.
Crossref
Xiaoqin Ma, Chenxia Hao, Meixiang Yu, Zhaokang Zhang, Jingjing Huang & Wanhua Yang. (2022) Investigating the Molecular Mechanism of Quercetin Protecting against Podocyte Injury to Attenuate Diabetic Nephropathy through Network Pharmacology, MicroarrayData Analysis, and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Rasheed Ibrahim, Mutiu Alabi, Babalola Yusuf, Latifat Ibrahim, Jamiu Ahmad, Kehinde Ogunyale, Esther Oladiji & Rihanat Bashir. (2022) Senna occidentalis Leaf Extracts Ameliorate Biochemical Parameters of Diabetic Nephropathy in Diabetic Wistar Rats. Journal of Medical Sciences 22:4, pages 208-218.
Crossref
Divya Balu, Vasanthan Krishnan, Vengadakrishnan Krishnamoorthy, RB Sudagar Singh, Senthil Narayanasamy & Gnanasambandan Ramanathan. (2022) Does serum kidney injury molecule-1 predict early diabetic nephropathy: A comparative study with microalbuminuria. Annals of African Medicine 21:2, pages 136.
Crossref
Vikram Patial, Garima Dadhich & Rajiv Kumar. 2022. Sustainable Agriculture Reviews 57. Sustainable Agriculture Reviews 57 27 69 .
Elfiani Elfiani, Anggelia Puspasari & Zulkhair Ali. 2022. Biomarkers in Diabetes. Biomarkers in Diabetes 1 16 .
Bamidele Stephen Ajilore & Bosede Olaitan Ajilore. 2022. Biomarkers in Diabetes. Biomarkers in Diabetes 1 18 .
E. B. Popykhova, A. N. Ivanov, T. V. Stepanova, D. D. Lagutina & A. A. Savkina. (2021) Diabetic Nephropathy – possibilities of early laboratory diagnostics and course prediction (review of literature). Russian Clinical Laboratory Diagnostics 66:10, pages 593-602.
Crossref
Shahira M. Ezzat, Heba M.I. Abdallah, Noha N. Yassen, Rasha A. Radwan, Eman S. Mostafa, Maha M. Salama & Mohamed A. Salem. (2021) Phenolics from Physalis peruviana fruits ameliorate streptozotocin-induced diabetes and diabetic nephropathy in rats via induction of autophagy and apoptosis regression. Biomedicine & Pharmacotherapy 142, pages 111948.
Crossref
Anqi Chen, Hailing Wang, Ying Su, Chunlin Zhang, Yanmei Qiu, Yifan Zhou, Yan Wan, Bo Hu & Yanan Li. (2021) Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications. Frontiers in Endocrinology 12.
Crossref
Marwa Jaaban, Almoutassem Billah Zetoune, Sondos Hesenow & Razan Hessenow. (2021) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon 7:7, pages e07564.
Crossref
Mei Jing, Yun Cen, Fangfang Gao, Ting Wang, Jinxin Jiang, Qianqian Jian, Liangmiao Wu, Baojian Guo, Fangcheng Luo, Gaoxiao Zhang, Ying Wang, Lipeng Xu, Zaijun Zhang, Yewei Sun & Yuqiang Wang. (2021) Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease. Frontiers in Pharmacology 12.
Crossref
Ievgeniia A. Burlaka, Inga O. Mityuryayeva, Tetiana A. Shevchenko, Anastasiia D. Holoborodko, Ihor V. Kovalchuk & Lilia O. Lantukh. (2021) Clinical, Laboratory, Instrumental, Anamnestic Characteristics in Children With Type I Diabetes Mellitus and Early Stage of Diabetic Nephropathy. Global Pediatric Health 8, pages 2333794X2110630.
Crossref
Rabia Khan, Ammar Ahmed Siddiqui, Freah Alshammary, Sameer Shaikh, Junaid Amin & Hassaan Anwer Rathore. 2020. Handbook of Healthcare in the Arab World. Handbook of Healthcare in the Arab World 1 24 .
Rabia Khan, Ammar Ahmed Siddiqui, Freah Alshammary, Sameer Shaikh, Junaid Amin & Hassaan Anwer Rathore. 2021. Handbook of Healthcare in the Arab World. Handbook of Healthcare in the Arab World 1029 1051 .
Irena Kostovska, Katerina Tosheska Trajkovska, Svetlana Cekovska, Sonja Topuzovska, Julijana Brezovska Kavrakova, Goce Spasovski, Ognen Kostovski & Danica Labudovic. (2020) Role of urinary podocalyxin in early diagnosis of diabetic nephropathy. Romanian Journal of Internal Medicine 58:4, pages 233-241.
Crossref
Ya-yi Jiang, Jia-cheng Shui, Bo-xun Zhang, Jia-wei Chin & Ren-song Yue. (2020) The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus. Frontiers in Pharmacology 11.
Crossref
Samuel N Uwaezuoke & Adaeze C Ayuk. (2020) Diabetic Kidney Disease in Childhood and Adolescence: Conventional and Novel Renoprotective Strategies. EMJ Nephrology, pages 68-77.
Crossref
Gnanamoorthy Kothai, Kumaravel Neha, Aruna Bholenath Patil, Athanallur Raman Malathy & Suthakaran Prasanna Karthik. (2020) Neutrophil Lymphocyte Ratio as a Marker of Diabetic Nephropathy. Journal of Evidence Based Medicine and Healthcare 7:26, pages 1223-1227.
Crossref
Megha A. Deshmukh, Jun-Young Jeon & Tae-Jun Ha. (2020) Carbon nanotubes: An effective platform for biomedical electronics. Biosensors and Bioelectronics 150, pages 111919.
Crossref
J. Seyfarth, D. Herebian, C. Reinauer, C. Baechle, M. Roden, R. W. Holl, T. Reinehr, E. Mayatepek, T. Meissner & J. Rosenbauer. (2019) Evaluation of lipoprotein‐associated phospholipase A2 as a marker for renal microvasculopathy in adolescents with Type 1 diabetes. Diabetic Medicine 37:1, pages 75-83.
Crossref
Sedigheh Shahvali, Armita Shahesmaeili, Mojgan Sanjari & Somayyeh Karami-Mohajeri. (2019) The correlation between blood oxidative stress and sialic acid content in diabetic patients with nephropathy, hypertension, and hyperlipidemia. Diabetology International 11:1, pages 19-26.
Crossref
Marina Ruxandra Oțelea & Daniela Dragu. (2019) Diabetic nephropathy in type 2 diabetes – from pathological mechanisms to clinical occupational medicine practice. Romanian Journal of Occupational Medicine 70:1, pages 52-57.
Crossref
Hua Wei, Jianzhou Li, Yanhua Li & Jian Song. (2019) MicroRNA-451 inhibits inflammation and proliferation of glomerular mesangial cells through down-regulating PSMD11 and NF-κB p65. Bioscience Reports 39:10.
Crossref
Jin Bai, Yi Wang, Xiaoguang Zhu & Jun Shi. (2019) Eriodictyol inhibits high glucose‐induced extracellular matrix accumulation, oxidative stress, and inflammation in human glomerular mesangial cells. Phytotherapy Research 33:10, pages 2775-2782.
Crossref
Vibeke Bratseth, Gemma Chiva-Blanch, Rune Byrkjeland, Svein Solheim, Harald Arnesen & Ingebjørg Seljeflot. (2019) Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training. Diabetes and Vascular Disease Research 16:5, pages 431-439.
Crossref
Sang Bae Lee, Yu-Sik Kim, Jung Hye Kim, Kahui Park, Ji Sun Nam, Shinae Kang, Jong Suk Park, Sehyun Shin & Chul Woo Ahn. (2019) Use of RBC deformability index as an early marker of diabetic nephropathy. Clinical Hemorheology and Microcirculation 72:1, pages 75-84.
Crossref
Qinghua Cao, Xin‐Ming Chen, Chunling Huang & Carol A. Pollock. (2019) MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update. FASEB BioAdvances 1:6, pages 375-388.
Crossref
Walaa H. Mohammad, Ahmad B. Ahmad, Muhammad H. Al-Maghraby, Mohamed Z. Abdelrhman & Sanaa Ezzate. (2019) Is neutrophil-lymphocyte ratio a novel biomarker for macrovascular and microvascular complications of type 2 diabetes?. The Egyptian Journal of Internal Medicine 31:1, pages 1-7.
Crossref
Min Xiang, Zhihong Chen, Liangping He, Guoliang Xiong & Jiandong Lu. (2019) Transcription profiling of artemisinin-treated diabetic nephropathy rats using high-throughput sequencing. Life Sciences 219, pages 353-363.
Crossref
Xiaomin Zhang, Kaiwen Guo, Feng Xia, Xinyu Zhao, Zhifeng Huang & Jianlou Niu. (2018) FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation. BMC Biotechnology 18:1.
Crossref
Samuel N. Uwaezuoke, Ugo N. Chikani & Ngozi R. Mbanefo. 2018. Advances in Nephropathy. Advances in Nephropathy.
Skander Mulder, Habib Hamidi, Matthias Kretzler & Wenjun Ju. (2018) An integrative systems biology approach for precision medicine in diabetic kidney disease. Diabetes, Obesity and Metabolism 20, pages 6-13.
Crossref
Yan‐Zhe Wang, Wen‐Wei Xu, Ding‐Yu Zhu, Nan Zhang, Yong‐Lan Wang, Miao Ding, Xin‐Miao Xie, Lin‐Lin Sun & Xiao‐Xia Wang. (2018) Specific expression network analysis of diabetic nephropathy kidney tissue revealed key methylated sites. Journal of Cellular Physiology 233:10, pages 7139-7147.
Crossref
Samuel N. Uwaezuoke. 2018. Biomarker - Indicator of Abnormal Physiological Process. Biomarker - Indicator of Abnormal Physiological Process.
Tao Ding, Shaofei Wang, Xuyao Zhang, Wenjing Zai, Jiajun Fan, Wei Chen, Qi Bian, Jingyun Luan, Yilan Shen, Yanda Zhang, Dianwen Ju & Xiaobin Mei. (2018) Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine 41, pages 45-53.
Crossref